Precision BioSciences Inc (NAS:DTIL)
$ 7.29 0.18 (2.53%) Market Cap: 55.92 Mil Enterprise Value: -14.97 Mil PE Ratio: 121.50 PB Ratio: 0.84 GF Score: 59/100

Precision BioSciences Inc Annual Shareholders Meeting Transcript

May 10, 2021 / 03:00PM GMT
Release Date Price: $242.1 (-6.00%)
Matt Kane
Precision BioSciences, Inc. - CEO, Co-Founder, Director

Good morning. My name is Matt Kane, and I am the Chief Executive Officer and Co-Founder of Precision BioSciences. I'm also a member of our Board of Directors and the Chairperson of today's meeting, and I'm happy to welcome you to our annual meeting of stockholders.

Before I call the meeting to order, I'd like to introduce Kevin Buehler, Chairman of the Board of Directors for Precision BioSciences.

Kevin Buehler
Precision BioSciences, Inc. - Chairman of the Board

Good morning, ladies and gentlemen. Thank you for joining us today for the annual meeting of stockholders. I'm joined today by my fellow Board members, including Dr. Derek Jantz, Chief Scientific Officer and Co-Founder of Precision BioSciences; Dr. Stanley Frankel; Geno Germano; Dr. Raymond Schinazi; and Dr. Tony Yao.

Before I turn the call back to Matt, I'd like to recognize the important work by him, his leadership team, and the entire company for the progress they have made this past year. The company has created

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot